Keyphrases
Breast Cancer
100%
Optical Imaging
100%
Nanobody
100%
Optical Treatment
100%
HER2-targeted Therapy
100%
HER2 Receptor
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Tumor
20%
Trastuzumab
15%
Monoclonal Antibody
15%
IRDye
15%
HER2-positive
10%
Molecular Status
10%
HER2-positive Breast Cancer
5%
Breast Cancer Patients
5%
Ribonuclease
5%
Fluorophore
5%
Photosensitizer
5%
Canine
5%
Electron Microscopy
5%
Treatment Options
5%
Initial Treatment
5%
Cancer Cells
5%
Therapeutic Approaches
5%
High Affinity
5%
Site-specific Conjugation
5%
HER2-positive Tumors
5%
IRDye800CW
5%
Conjugation
5%
Imaging Approach
5%
Overexpressing
5%
Conventional Antibodies
5%
Heavy-chain Antibody
5%
After Injection
5%
Breast Tumor
5%
Radiation-based Method
5%
Targeted Nanoparticles
5%
Complex Disease
5%
Tumor Site
5%
Patient Treatment
5%
Photodynamic Therapy
5%
Camelidae
5%
Herceptin
5%
Early Cancer Detection
5%
Near-infrared Dye
5%
Aggressive Disease
5%
Prevalent Cancers
5%
Breast Cancer Imaging
5%
HER2-positive Cancer
5%
Chemical Base
5%
Drug Lead
5%
Naturally-derived
5%
Pharmacology, Toxicology and Pharmaceutical Science
Optical Imaging
100%
Nanobody
100%
Breast Cancer
100%
Neoplasm
35%
Receptor
30%
Trastuzumab
20%
Malignant Neoplasm
15%
Monoclonal Antibody
15%
Diseases
10%
Electron Microscopy
5%
Photodynamic Therapy
5%
Camelid
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
5%
Ribonuclease
5%
Nanoparticle
5%
Photosensitizer
5%
Medicine and Dentistry
Breast Cancer
100%
Optical Imaging
100%
Nanobody
100%
Neoplasm
35%
Receptor
30%
Trastuzumab
20%
Monoclonal Antibody
15%
Diseases
10%
Malignant Neoplasm
5%
Electron Microscopy
5%
Photosensitizer
5%
Cancer Cell
5%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
5%
Ribonuclease
5%
Early Cancer Diagnosis
5%
Heavy Chain
5%
Nanoparticle
5%
Photochemotherapy
5%
Neuroscience
Single-Domain Antibody
100%
Optical Imaging
100%
Receptor
30%
Trastuzumab
20%
Monoclonal Antibody
15%
In Vivo
5%
Staining Technique
5%
Electron Microscopy
5%
Ribonuclease
5%
Heavy Chain
5%
Biochemistry, Genetics and Molecular Biology
Optical Imaging
100%
Single-Domain Antibody
100%
Trastuzumab
20%
Monoclonal Antibody
15%
Ribonuclease
5%
RNA
5%
Infrared Radiation
5%
In Vivo Study
5%
Electron Microscopy
5%
Heavy Chain
5%
Photodynamics
5%
Enzyme
5%
Cancer Cell
5%
Camelid
5%
Immunology and Microbiology
Single-Domain Antibody
100%
Trastuzumab
20%
Monoclonal Antibody
15%
Electron Microscopy
5%
Photodynamics
5%
Cancer Cell
5%
Camelid
5%
Heavy Chain
5%
Infrared Radiation
5%